Pfizer Leading Investment Round in Essa (EPIX) for mCRPC
Insights - Essa (EPIX) announced an offering after market today. Although details on amount and pricing have not yet been disclosed, we think there will be strong … Continue Reading
PremiumMust Read
Obesity & PD-1: History Doesn’t Repeat But It Rhymes
The early innings of the obesity landscape is starting to take shape, and it seems to be forming similar patterns...
Read NowModular Medical Submits 510(k) for Insulin Patch Pump
Modular Medical (MODD) announced the 510(k) submission of their MODD1 insulin pump to the FDA last week. On average, the FDA takes approximately...
PremiumLatest Posts
Essa’s First Dosed Patient in mCRPC Finally Catches Market’s Attention
Insights - Yesterday Essa (EPIX) announced it dosed the first patient in their Phase 1 mCRPC study. EPIX is up 30% since we first covered it back in late … Continue Reading
Premium
AC Immune & Janssen Tau Vaccine Shows Efficacy in Alzheimer’s Disease
Insights - AC Immune (ACIU) is up 60% in pre-market after the company announced it was advancing their anti-tau vaccine in Alzheimer’s Disease (AD) to higher dosing cohorts. Although … Continue Reading
Read now
This Compay Is Vital To Gene Therapy Becoming a Commercial Success
Insights - Magenta (MGTA) is pursuing two of the largest challenges in stem cell transplants; mobilizing stem cells and conditioning patients for transplants. Overcoming these challenges will … Continue Reading
Premium
Bellus Data Flop Catches Market By Surprise
Insights - Bellus announced Phase 2 data this morning and it was a major flop. The stock is down 75%. Bellus did not hit statistical significance in any of … Continue Reading
Premium
DON’T CONFUSE A MEDICAL DEVICE “CLEARANCE” WITH “APPROVAL”
Education - New investors often confused medical device 510k clearance with FDA approval. The hurdles are quite different. Here's what you need to know.
Read now
Taking Advantage of Fennec’s Rally Ahead of PDUFA
Insights - Fennec is up 50% since announcing their financing on April 30, 2020 @ 6.25/share. During this time, volume has picked up significantly, with 8.5M total … Continue Reading
Premium